{"id":"https://openalex.org/W4401878489","doi":"https://doi.org/10.1016/s2152-2650(24)00349-5","title":"Asparaginase: Optimizing Efficacy and Minimizing Toxicity in Pediatric and AYA ALL/LBL","display_name":"Asparaginase: Optimizing Efficacy and Minimizing Toxicity in Pediatric and AYA ALL/LBL","publication_year":2024,"publication_date":"2024-08-26","ids":{"openalex":"https://openalex.org/W4401878489","doi":"https://doi.org/10.1016/s2152-2650(24)00349-5"},"language":"en","primary_location":{"id":"doi:10.1016/s2152-2650(24)00349-5","doi":"https://doi.org/10.1016/s2152-2650(24)00349-5","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1016/s2152-2650(24)00349-5","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036550103","display_name":"Rachel E. Rau","orcid":"https://orcid.org/0000-0003-4096-6603","observed_orcids":["https://orcid.org/0000-0003-4096-6603"]},"institutions":[{"id":"https://openalex.org/I1295499534","display_name":"Seattle Children's Hospital","ror":"https://ror.org/01njes783","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295499534"]},{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rachel E. Rau","raw_affiliation_strings":["Seattle Children's Hospital, Cancer and Blood Disorders Center","University of Washington, Department of Pediatrics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle Children's Hospital, Cancer and Blood Disorders Center","institution_ids":["https://openalex.org/I1295499534"]},{"raw_affiliation_string":"University of Washington, Department of Pediatrics","institution_ids":["https://openalex.org/I201448701"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5036550103"],"corresponding_institution_ids":["https://openalex.org/I1295499534","https://openalex.org/I201448701"],"apc_list":{"value":3780,"currency":"USD","value_usd":3780},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.17155273,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"24","issue":null,"first_page":"S64","last_page":"S66"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/l-asparaginase","display_name":"L-asparaginase","score":0.9929999709129333},{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.8730000257492065},{"id":"https://openalex.org/keywords/pediatric-leukemia","display_name":"pediatric leukemia","score":0.8629999756813049},{"id":"https://openalex.org/keywords/adolescent-and-young-adult-leukemia","display_name":"adolescent and young adult leukemia","score":0.843999981880188},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.5920000076293945},{"id":"https://openalex.org/keywords/toxicity-management","display_name":"toxicity management","score":0.47699999809265137}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9428973197937012},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5735209584236145},{"id":"https://openalex.org/C2778904437","wikidata":"https://www.wikidata.org/wiki/Q105296036","display_name":"Asparaginase","level":4,"score":0.47687822580337524},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.33589673042297363},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3315611481666565},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2511802911758423},{"id":"https://openalex.org/C2909962599","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic Leukemia","level":3,"score":0.11548638343811035},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.10251724720001221}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s2152-2650(24)00349-5","doi":"https://doi.org/10.1016/s2152-2650(24)00349-5","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1016/s2152-2650(24)00349-5","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1494880493","https://openalex.org/W1920035725","https://openalex.org/W1965542498","https://openalex.org/W1970810241","https://openalex.org/W1971882751","https://openalex.org/W1989771063","https://openalex.org/W2113512182","https://openalex.org/W2127219581","https://openalex.org/W2292251821","https://openalex.org/W2336096370","https://openalex.org/W2485785171","https://openalex.org/W2514790771","https://openalex.org/W2607911986","https://openalex.org/W2737192827","https://openalex.org/W2772927421","https://openalex.org/W2790444073","https://openalex.org/W2941871253","https://openalex.org/W2945356250","https://openalex.org/W2986362675","https://openalex.org/W3015698333","https://openalex.org/W3089122708","https://openalex.org/W3094939241","https://openalex.org/W3200345752","https://openalex.org/W4226201563","https://openalex.org/W4283716548","https://openalex.org/W4296637532","https://openalex.org/W4307038233","https://openalex.org/W4386949145","https://openalex.org/W4387764455"],"related_works":["https://openalex.org/W4412330683","https://openalex.org/W3156157995","https://openalex.org/W2593612450","https://openalex.org/W6986097873","https://openalex.org/W2011336486","https://openalex.org/W2896827153","https://openalex.org/W2401192361","https://openalex.org/W110983303","https://openalex.org/W2367944347","https://openalex.org/W4281726621"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-08-28T12:50:07.497085","created_date":"2024-08-27T00:00:00"}